Daedalus SPAC's Real Prize: A Bundle of 40 Tiny AI Apps Priced at $1.2 Billion

A four-year-old app studio in Izmir, Turkey, spent its whole life refusing outside money. It bootstrapped itself profitable, spun up 40-plus consumer apps, and never took a single dollar of venture capital. Then, within about ten days this summer, it took up to $75 million from Point72, Steve Cohen's firm, at a $1.2 billion valuation, and signed a non-binding letter of intent to go public on Nasdaq through a shell company called Daedalus Special Acquisition Corp. That compression is weird. The basic point is that HubX is a bundle of tiny AI apps, and a SPAC is the only packaging that lets a bundle like that get to the public market.

The bundle is the product

HubX is not really one company in the normal sense. It is a "hub" of consumer mobile and web apps — generative AI, education, health, fitness, photography — run as autonomous little studios sharing centralized marketing, data, and engineering. Its own materials count 40-plus products, 370-plus employees, and reach of more than 600 million users across 190-plus countries, and it says the portfolio is profitable. The names are things like Nova, Wiser, DaVinci, and Lotus Flow. These are small apps, individually far too small to justify their own listing.

Which is the point. Nobody IPOs a photo-editing utility. You IPO a collection of them. The asset going public is not a flagship app; it is the holding structure that owns 40-plus, plus the machine that keeps building and buying more. This is old finance in a new wrapper: HubX is a roll-up — a buy-and-build conglomerate of small consumer products — and the thing up for sale to public shareholders is the conglomerate, not any one product.

That also explains the sudden financialization. A bootstrapped studio can grow one app at a time out of cash flow. A roll-up cannot — the whole growth plan going forward is acquiring other people's proven apps and folding them into the shared distribution and AI machinery. That takes a war chest and a liquid equity currency, which is exactly what a de-SPAC provides: access to the cash sitting in the trust, plus a public stock to use in future acquisition deals. Point72's money funds the first acquisitions; the public listing funds the rest.

The shell on the other side

Daedalus was built to hunt this. It raised its IPO in December 2025, upsized to $250 million, with 100% of proceeds held in trust. Buyers paid $10 per unit for one share plus a quarter of a warrant exercisable at $11.50. Its stated search focus was consumer AI, fintech, mobile games, and corporate finance, and its two co-CEOs — Husnu Akin Babayigit, a managing director at Arcadia Interactive Partners, and Orkun Kilic, founder of the hedge fund Berry Street Capital — had exactly the sort of venture-and-capital-markets backgrounds that a consumer-AI roll-up would want. A SPAC has a clock: Daedalus has 24 months to close a deal, so roughly until December 2027. The HubX letter of intent, signed September 8, checks that box — tentatively.

Retail shareholders, meanwhile, are sitting at roughly $10.15, essentially the cash-in-trust value. That is the SPAC's defining feature and the reason it still trades there: people who bought these shares can, in principle, return them for the trust money rather than participate in whatever deal the sponsor strikes. Right now the down-protection is doing its job, and the upside is entirely the bet on this specific bundle — at a fair price — closing.

What's priced, and what isn't

Here is the rub, and it is worth being precise about. The letter of intent is non-binding, with the transaction structure and, crucially, the valuation left to be negotiated in definitive agreements and approved by shareholders. So there is no deal price yet. The only recent number hanging over the negotiation is Point72's: an investment of an initial $50 million, with an option for another $25 million, at a $1.2 billion pre-money valuation, completed at the end of August. That is the private-market anchor the de-SPAC will presumably be argued against. And note what retail would be buying at that anchor: the same bundle a sophisticated public-market adjacent private firm just endorsed at $1.2 billion, available through the shell.

But treat the optics carefully. The "600 million users" is cumulative reach across 190-plus countries, a downloads-style vanity number, not a count of people currently using the apps; the stocks and press releases also cite 100 million monthly users, which is a much more meaningful denominator, and even that is a company-disclosed figure. No revenue or profit figures are public, despite the profitable claim. And the math of a de-SPAC is not as glossy as the round: the sponsor's founder shares and the public warrants mean public holders absorb real dilution, so the effective price of the bundle to the trust's shareholders will be higher than the headline valuation suggests.

So the honest position for a retail buyer is structural, not a recommendation on a price that isn't public yet. You would be holding a $10 share with cash-in-trust protection — the downside is cushioned until a deal actually prices — and the upside is a bet that a profitable roll-up of small AI apps, freshly endorsed by Point72 at $1.2 billion, can survive the public-market conversion and an acquisition spree. The one number that should decide whether any of that matters is the one the letter of intent does not contain: the valuation HubX's founders roll their bundle into, and how much of the trust is still there after redemptions when the definitive agreement finally shows up.